| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/29/2008 | US7405319 Process for the preparation of carbamates |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
| 07/16/2008 | CN101223130A Glutamate aggrecanase inhibitors |
| 07/15/2008 | US7399884 Substituted benzamides; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations |
| 07/15/2008 | US7399787 Methods of treating cancer with HDAC inhibitors |
| 06/26/2008 | WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/26/2008 | CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/24/2008 | US7390926 Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3 |
| 06/19/2008 | WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity |
| 06/18/2008 | EP1931624A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 06/18/2008 | CN101203486A Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the efficiency of cytostatics and metastasis process |
| 06/18/2008 | CN101199537A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | CN101198586A Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 06/10/2008 | US7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 06/05/2008 | US20080132539 e.g. 2-amino-5-[(naphthalen-1-ylmethyl)-aminocarbonyl]-pentanoic acid hydroxyamide; advanced glycosylation endproducts inhibitor; diabetic neurosis, diabetic retinopathy, atherosclerosis, cataract, Alzheimer's disease, rheumatic arthritis, osteoarthritis, chronic renal failure; food and cosmetics |
| 06/04/2008 | EP1926728A1 Dioxazine- and oxadiazine-substituted arylamides |
| 06/03/2008 | US7381743 Macrocycles for the treatment of cancer |
| 05/29/2008 | WO2008061866A1 New benzamide derivatives |
| 05/28/2008 | EP1924643A2 Catalyst for making fluoroelastomer compositions and methods of using the same |
| 05/28/2008 | EP1603891B1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
| 05/28/2008 | CN100390141C Novel propargylether derivatives for controlling phytopathogenic microorganisms |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/20/2008 | US7375137 Methods of treating cancer with HDAC inhibitors |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/13/2008 | CA2323414C Cytostatic agents |
| 05/13/2008 | CA2264447C Process for the preparation of malononitrile |
| 05/07/2008 | CN101175709A P-tert-butylcalix[6]arenes with triacidic functions at 2, 4 and 6 supported liquid membranes support materials comprising the same and use thereof |
| 05/07/2008 | CN100386310C Method for producing N,N -dialkoxy-N,N -dialkyl oxamide |
| 05/06/2008 | US7368572 Anticancer agents |
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/24/2008 | US20080096889 Histone Deacetylases Inhibitors |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/15/2008 | US7358394 Process for preparing N,N′-dialkoxy-N, N′-dialkyl oxamide |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/10/2008 | WO2008040934A1 Hdac inhibitors |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/09/2008 | EP1906731A2 Novel hydroxamic acid-containing amino acid derivatives |
| 04/09/2008 | CN101156840A Inhibitors of oleamide hydrolase |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/25/2008 | US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070953 Inhibitors of interleukin-1 beta converting enzyme |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/12/2008 | EP1896399A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 03/06/2008 | US20080058323 Therapy of vascular system diseases |
| 03/06/2008 | CA2662218A1 Retinoid compounds and their use |
| 03/05/2008 | EP1894916A2 Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the efficiency of cytostatics and metastasis process inhibiting method |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/20/2008 | EP1888510A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/20/2008 | CN101128419A Process for preparing protected amiidines |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369887C Inhibitors of oleamide hydrolase |
| 02/13/2008 | EP1885682A2 P-tert-butylcalix[6]arenes with triacidic functions at 2, 4 and 6 supported liquid membranes support materials comprising the same and use thereof |
| 02/13/2008 | CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/05/2008 | US7326506 Bridged charge transport materials having a central sulfur atom linkage |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
| 01/30/2008 | EP1689350B1 Use of osteopontin in dental formulations |
| 01/29/2008 | US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/24/2008 | WO2008009264A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1567498B1 Mandelic acid derivatives |
| 01/17/2008 | US20080015216 Histone Deacetylase Inhibitors |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |
| 01/16/2008 | EP1877366A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | CA2265666C Cytostatic hydroxamic acid derivatives |
| 01/09/2008 | EP1874722A1 Hydroxamic acid derivatives and the preparation method thereof |
| 01/09/2008 | CN100360580C Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 01/08/2008 | CA2408602C Phenylglycine derivatives |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/01/2008 | US7314953 Treatment of lung cells with histone deacetylase inhibitors |
| 12/26/2007 | EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors |
| 12/26/2007 | CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds |
| 12/25/2007 | US7312247 Histone deacetylase inhibitors |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/19/2007 | CN100355721C Analogous compounds of strobilurines and their use as acaricides and insecticides |
| 12/12/2007 | EP1349869A4 Method of identifying antibacterial compounds |